India looks for test kits from South Korea

South Korea is proving out to be an important source of medical supplies for India among the countries for novel coronavirus with aggressive testing and contact tracing. The Indian embassy in Seoul signed an agreement for supply of 5,00,000 rapid test kits from a South Korean company to the ICMR.

According to the agreement, the kits will be delivered in 4 separate consignments, the first of which will reach India April 30.

The procurement will help scale up the availability of tests which is a “big weapon’’ in the fight against Covid-19 said, India’s ambassador to South Korea Sripriya Ranganathan

“It’s not a buyer’s market but the goodwill which India enjoys with the South Korean government and its people has meant that the manufacturers are much more receptive to our needs and more flexible in meeting our demands.”

Ranganathan further added that, ‘all procurement is certified for export and subject to quality checks. “These have been found suitable for use by the ICMR. The company with which the embassy has signed the agreement is sourcing raw materials for production of the diagnostic testing kits from India, a collaboration described as a tribute to the special strategic partnership between the 2 countries.”

“It wasn’t that the Koreans from the start had the option of walking up to a hospital and getting themselves tested. It was also very expensive initially but they built up their capacity over a period of time by making tests available. Over 2 months, they pumped more tests into their healthcare system and spread the net wide as out agencies are doing now in India,’’ she said.

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    PGIMS recalls drug amid probe into deaths

    PGIMS recalls drug amid probe into deaths

    NPPA list brings little relief: No price cut for 25% cancer drugs

    NPPA list brings little relief: No price cut for 25% cancer drugs

    Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

    Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

    For Aakash Healthcare, Community People are Apples of its Eyes

    For Aakash Healthcare, Community People are Apples of its Eyes

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Yashoda Medicity: Baby takes a Giant Step in just One Year

    Yashoda Medicity: Baby takes a Giant Step in just One Year